General Nephrology – Other

T GUTMAN1,2, P LOPEZ-VARGAS2, K MANERA1,2, J CRAIG1,2, M HOWELL1,2, D TUNNICLIFFE2, L JAMES1,2, R MACGINLEY3, E SEE4, J WONG5, D VOSS6, J SAUNDERS7, SOLOMON MENAHEM8, SHILPANJALI JESUDASON9, ALLISON TONG1,2, PAUL CHAMPION DE CRESPIGNY10 1School of Public Health, The University...
  • 7 June 2018
Read More
T GUTMAN1,2,  M HOWELL1,2, K DANSIE3,  CHAWLEY4,5,9,  J CRAIG1,2,6, A TONG1,2, S JESUDASON7,10,11, J CHAPMAN8,  D JOHNSON4,9, L MURPHY10, D REIDLINGER4,5, S MCDONALD3,7,11 1School of Public Health, The University Of Sydney, Sydney, Australia, 2Centre for Kidney Research, The Children’s Hospital...
  • 7 June 2018
Read More
S BEK1, B USTUNER1, N EREN1 1Kocaeli University Hospital, Kocaeli, Turkey Aim: To evaluate the association between hepcidin and metabolic syndrome in chronic kidney disease (CKD). Background: Hepcidin is an antimicrobial peptide and regulator of iron homeostasis; synthesized in the...
  • 7 June 2018
Read More
A DING1, S WALTON2, K MORITZ2,3, J PHILLIPS1 1Department of Biomedical Science, Macquarie University, Sydney, Australia, 2School of Biomedical Sciences, University of Queensland, Brisbane, Australia, 3Child Health Research Centre, University of Queensland, Brisbane, Australia Aim: To determine if improved pre-and/or...
  • 7 June 2018
Read More
T CHANG1, T DAVIDSON2 1The Wollongong Hospital, Wollongong, Australia, 2Prince of Wales Hospital, Randwick, Australia Background: MYH9 gene encodes non-muscle-myosin-IIA (NMMHC-IIA) with expression in renal podocytes. MYH9 is increasingly recognised as a renal susceptibility gene. May-Hegglin anomaly (MHA) is a...
  • 7 June 2018
Read More
A JEYARUBAN1,2,3, WE HOY1,2, A CAMERON1,2,  HG HEALY1,2,3, J ZHANG1,2, AJ MALLETT1,2,3 1CKD.QLD and NHMRC CKD.CRE, Brisbane, Australia, 2Faculty of Medicine, The University of Queensland, Herston, Australia, 3Kidney Health Service, Royal Brisbane and Women’s Hospital, Herston, Australia Aim: To investigate...
  • 7 June 2018
Read More
Categories